Helsinki University Central Hospital, Meilahti Hospital
Helsinki, 00029, Finland
NCT Number: NCT01283815
According to retrospective studies the conservative management of periappendicular abscess is associated with decreased complication and re-operation rate compared with open appendectomy. Large abscesses require percutaneous drainage. Sometimes percutaneous drainage is not possible because of anatomical position of the abscess and surgical treatment is needed. The purpose of this study is evaluate whether laparoscopic appendectomy is suitable for the first-line treatment in patients with periappendicular abscess.
The hypothesis of the study is that laparoscopic management of periappendicular abscess is suitable for the first-line treatment and it does not increase time of hospitalization or complication rate compared with conservative management.
Looking for future studies?
Notify Me18 year–80 year
All sexes
Interventional
Phase 2
Helsinki, 00029, Finland
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Laparoscopic appendectomy and laparoscopic drainage of the abscess. If appendectomy is not possible due to technical difficulties only laparoscopic drainage is performed. Patients are treated with the same antimicrobial therapy as the control group (intravenous Cefuroxime 1,5 g x 3 per day plus Metronidazole 500 mg x 3 per day).
Patients are treated with intravenous Cefuroxime 1,5 g x 3 per day plus Metronidazole 500 mg x 3 per day. If the abscess is at least 3 cm in diameter percutaneous ultrasound guided drainage is performed.
Time frame: Day 60 after randomization
Time frame: Within the first 60 days after randomization
Interventions include percutaneous drainage and operations
Time frame: On day 7 after randomization
Time frame: During the first 24 hours after randomization
In the laparoscopy group appendectomy was not possible. In the conservative group planned percutaneous drainage was not possible.
Time frame: Within 60 days from randomization
Any complication occurring within 60 days from randomization. Both medical and surgical complications are included.
Time frame: Within 60 days after randomization
Helsinki University Central Hospital
Other
Laparoscopic Management of Periappendicular Abscess - Randomized Controlled Trial
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT01568853
Abdominal Abscess, Abscess
Nanjing, Jiangsu, China
View Trial DetailsNCT00230971
Abdominal Abscess, Abscess
Nambour, Queensland, Australia
View Trial DetailsNCT05002829
Appendicitis, Cecal Diseases
Denver, Colorado, United States
View Trial DetailsNCT05887414
Appendicitis, Cecal Diseases
Baldwin Park, California, United States
View Trial Details